Solventum Corp. (SOLV) — chart, structure and Closelook read

Pick a ticker to load its detail page.

Company snapshot — Solventum Corp.

SOLV in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Solventum makes medical and dental products and software for hospitals, clinics and dental practices, split across three segments: Medsurg, which covers wound care, skin care, sterilisation and surgical supplies; Dental Solutions, covering orthodontic and restorative dental products; and Health Information Systems, which sells software for clinical documentation, coding and speech recognition. It sells directly, through distributors and online. The company was carved out of 3M, incorporated in 2023 and listed through an initial public offering in 2024. It is based in Eagan, Minnesota.
Where it sits in the stack
Solventum sits outside our AI build-out index; it belongs to the medical instruments and supplies sleeve of our wider universe, alongside other healthcare-equipment names we track separately from the chip and data-centre chain.
Who it is priced against
The diary has no assigned peer group for this name; the comparison the market still draws is with 3M, the company it was spun out from.
Why Closelook tracks it
Solventum holds a seat in the S&P 500 but carries no Closelook score and has not yet appeared in the diary's editions or quotes.
What the diary watches
Whether the Health Information Systems segment keeps growing faster than Medsurg and Dental Solutions, which would change how the diary reads the mix as a standalone company.

Solventum Corp. (SOLV) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for SOLV, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Medical Instruments & Supplies · United States · 8 names with week and year-to-date

Peer group

Medical Instruments & Supplies · United States

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against SOLV on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 50/100 · S&P 500 fund at 49, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-18
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 97th percentile of the window, +4.9% over 20 sessions. Factor regime → 2026-09-18
  • Sovereign pressure Index 0.07 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-18

FAQ · from the current data · as of 2026-09-19

Quick answers

What is Solventum Corp. (SOLV)?

Solventum Corp. trades as SOLV on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-19.

Is SOLV in a Closelook index?

Not currently — Solventum Corp. is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-19.

Where does SOLV trade against its moving averages?

Uptrend stack intact: Trades +3.2% vs the 50-day and +14.4% vs the 200-day average, 5.6% below the 52-week high and +42.4% off the 52-week low; a golden cross printed 56 sessions ago. Computed from daily closes. As of 2026-09-18 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Solventum Corp. do?

Solventum makes medical and dental products and software for hospitals, clinics and dental practices, split across three segments: Medsurg, which covers wound care, skin care, sterilisation and surgical supplies; Dental Solutions, covering orthodontic and restorative dental products; and Health Information Systems, which sells software for clinical documentation, coding and speech recognition. It sells directly, through distributors and online. The company was carved out of 3M, incorporated in 2023 and listed through an initial public offering in 2024. The diary has no assigned peer group for this name; the comparison the market still draws is with 3M, the company it was spun out from.

Where does Solventum Corp. sit in the AI build-out?

Solventum sits outside our AI build-out index; it belongs to the medical instruments and supplies sleeve of our wider universe, alongside other healthcare-equipment names we track separately from the chip and data-centre chain. Solventum holds a seat in the S&P 500 but carries no Closelook score and has not yet appeared in the diary's editions or quotes.

What does this page show?

A live price chart with SMA overlays and drawing tools for SOLV, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Medical Instruments & Supplies. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.